Form 4 for PHVS Pharvaris N.V.
Accepted 2026-04-24 12:18:10 ET · period of report 2026-04-22 · accession 0001193125-26-176222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $7.62 | +7,600 | 56.5K | +16% | +$57.9K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,600 | 56.5K | -12% | -$228.4K |
| DMTI | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,100 | 156.9K | -4% | -$213.4K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Lesage Anne | Chief Early Development | M - OptEx | $0.00 | -7,600 | 15.9K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-22 | M | A | 500 | $2.59 | 56,950 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2026-04-22 | S | D | 500 | $30.00 | 56,450 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 3 | Common | Common Stock | 2026-04-22 | M | A | 7,000 | $8.05 | 63,450 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 4 | Common | Common Stock | 2026-04-22 | S | D | 7,000 | $30.05 | 56,450 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F2) These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13. |
| 5 | Common | Common Stock | 2026-04-22 | S | D | 7,000 | $30.05 | 156,969 | I GrayMatters Consulting B.V. | — | — | (F2) These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13. |
| 6 | Common | Common Stock | 2026-04-23 | S | D | 100 | $30.03 | 156,869 | I GrayMatters Consulting B.V. | — | — | |
| 7 | Common | Common Stock | 2026-04-23 | M | A | 100 | $2.59 | 56,550 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 8 | Common | Common Stock | 2026-04-23 | S | D | 100 | $30.03 | 56,450 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F3) These shares were sold in multiple transactions at prices ranging from $30.03 to $31.03. |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 500 | $0.00 | 15,972 | D | $2.59 · — to 2030-01-01 | 500 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F4) 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2026-04-22 | M | D | 7,000 | $0.00 | 113,000 | D | $8.05 · — to 2031-02-05 | 7,000 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F5) 25% of the option vested on February 5, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-04-23 | M | D | 100 | $0.00 | 15,872 | D | $2.59 · — to 2030-01-01 | 100 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F4) 25% of the option vested on January 1, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. |